MarketsSingle-source
2.0
Acura Pharmaceuticals files 8-K regarding material asset acquisition and financial obligations
SEC EDGAR 8-K FilingsLO·US·2 days ago
Bleichroeder Acquisition Corp. II has filed an 8-K disclosing entry into a material definitive agreement. The specific nature of the agreement, such as a merger or acquisition target, remains undisclosed pending further exhibit filings.